Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
Phase of Trial: Phase I
Latest Information Update: 05 May 2009
At a glance
- Drugs Anecortave (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 07 May 2007 Status changed from recruiting to discontinued.
- 17 Dec 2005 New trial record.